Strategic Acquisition ScoutPro Osmolarity System is now part of the Bausch + Lomb portfolio, indicating strong channel support and potential access to a broader ophthalmology customer base through an established medical device giant.

Dry Eye Focus Recent news shows Bausch + Lomb expanding its dry eye market presence, with ScoutPro and TearLab lineage reinforced by Trukera acquisition, signaling growing demand for objective tear osmolarity solutions among eye care practices.

Global Distribution Partnerships like Topcon distributing ScoutPro in the UK and Ireland suggest opportunities to leverage international channels and co-sell with distributors to penetrate new geographies.

Financial Scale Revenue range and substantial funding indicate a viable, mid-size growth company with budgetary room for clinical adoption programs, training initiatives, and bundled offerings to ophthalmology clinics.

Clinical Differentiator As the first point-of-care system delivering objective tear osmolarity data, ScoutPro offers a compelling value proposition to clinics for decision support, enabling sales opportunities around diagnostic workflows and patient management.